Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan R Targan

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Annals of the New York Academy of Sciences|October 24, 2006
Current limitations of IBD treatment: where do we go from here?Stephan R Targan
Advances in Experimental Medicine and Biology|December 15, 2010
Introductory words about TL1A/DR3Stephan R Targan
Advances in Experimental Medicine and Biology|April 20, 2006
Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel diseaseJonathan Braun, Stephan R Targan
Inflammatory Bowel Diseases|March 15, 2008
Ex vivo simulation of IgG Fc and T-cell receptor functions: an application to inflammatory bowel diseaseMasato Mitsuhashi, Stephan R Targan
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
CD56 marks an effector T cell subset in the human intestineOffer Cohavy, Stephan R Targan
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
Future biologic targets for IBD: potentials and pitfallsGil Y Melmed, Stephan R Targan
Current Gastroenterology Reports|November 12, 2009
Insights into IBD PathogenesisDavid Q Shih, Stephan R Targan
Immunological Reviews|July 29, 2005
Defects in mucosal immunity leading to ulcerative colitisStephan R Targan, Loren C Karp
World Journal of Gastroenterology|January 18, 2008
Immunopathogenesis of inflammatory bowel diseaseDavid Q Shih, Stephan R Targan
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
TL1A: A model for a precision medicine approach in the treatment of Crohn's disease and ulcerative colitisJanine M Bilsborough, Stephan R Targan
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Annals of the New York Academy of Sciences|October 24, 2006
Current limitations of IBD treatment: where do we go from here?Stephan R Targan
Advances in Experimental Medicine and Biology|December 15, 2010
Introductory words about TL1A/DR3Stephan R Targan
Advances in Experimental Medicine and Biology|April 20, 2006
Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel diseaseJonathan Braun, Stephan R Targan
Inflammatory Bowel Diseases|March 15, 2008
Ex vivo simulation of IgG Fc and T-cell receptor functions: an application to inflammatory bowel diseaseMasato Mitsuhashi, Stephan R Targan
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
CD56 marks an effector T cell subset in the human intestineOffer Cohavy, Stephan R Targan
Nature Reviews. Gastroenterology & Hepatology|February 6, 2010
Future biologic targets for IBD: potentials and pitfallsGil Y Melmed, Stephan R Targan
Current Gastroenterology Reports|November 12, 2009
Insights into IBD PathogenesisDavid Q Shih, Stephan R Targan
Immunological Reviews|July 29, 2005
Defects in mucosal immunity leading to ulcerative colitisStephan R Targan, Loren C Karp
World Journal of Gastroenterology|January 18, 2008
Immunopathogenesis of inflammatory bowel diseaseDavid Q Shih, Stephan R Targan
Advances in Pharmacology (San Diego, Calif.)|November 9, 2024
TL1A: A model for a precision medicine approach in the treatment of Crohn's disease and ulcerative colitisJanine M Bilsborough, Stephan R Targan
Pageof 19